Sula Vineyards share pros and cons: India’s wine market monopoly franchise at expensive micro-cap PE with state excise dependency analysed for 2026.

Rainbow Children’s Medicare share pros and cons: India’s largest paediatric hospital chain at 55x PE with NICU leadership analysed for 2026.

Minda Corporation share pros and cons: auto electrical wiring harness and castings at 47.81x PE versus UNO Minda comparison analysed for 2026.

Aster DM Healthcare share pros and cons: South India hospital chain at transition PE post-GCC demerger analysed for 2026.

Ajanta Pharma share pros and cons: Africa and Asia branded pharma leader at reasonable 38x PE with 23.3% ROE analysed for 2026.

KIMS share pros and cons: AP and Telangana hospital chain with IHH Healthcare at expansion-phase 174x PE analysed for 2026.

Multibase India Q1 FY27 results: Revenue Rs 20 Cr, PAT Rs 3 Cr. Key highlights, performance, FY27 outlook. Read full results analysis here.

Star Cement Q1 FY27 results: Revenue Rs 942 Cr (+3.39% YoY), PAT Rs 73 Cr (-24.71% YoY). Key highlights, financial analysis and FY27 outlook.

Maharashta Seamless Q1 FY27 results: Revenue Rs 1,091 Cr (-4.72% YoY), PAT Rs 270 Cr (+15.69% YoY). Key highlights, financial analysis and FY27 outlook.

Starteck Finance Q1 FY27 results: Revenue Rs 10 Cr, PAT Rs 4 Cr. Key highlights, performance, FY27 outlook. Read full results analysis here.